Evidence map›Paper›PMID 21439856›Full record

ArticleImmunity2011

CD94 is essential for NK cell-mediated resistance to a lethal viral disease.

Min Fang, Mark T Orr, Pieter Spee, Thomas Egebjerg, Lewis L Lanier, Luis J Sigal

Abstract read
In one paragraph

Article in Immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. CD94The European respiratory journal · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Min FangImmune Cell Development and Host Defense Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Mark T Orr
Pieter Spee
Thomas Egebjerg
Lewis L Lanier
Luis J Sigal
Fox Chase Cancer Center · USNovo Nordisk (Denmark) · DK

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
NK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0M
Orthropoxvirus Pathogenesis and VaccinesR01AI065544 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SIGAL, LUIS J · 2006 to 2016
$5.7M
MHC Class I Antigen Presentation in Viral InfectionsR01AI048849 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI SIGAL, LUIS J · 2001 to 2011
$3.8M
NK and T Cell Costimulation by NKG2D/DAP10R37AI066897 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2015
$3.8M
Mousepox in Aged MiceR21AI077021 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI SIGAL, LUIS J · 2007 to 2008
$466k
NCI NIH HHS CA006927NCI NIH HHS P30 CA006927NIAID NIH HHS AI066897NIAID NIH HHS R01 AI048849NIAID NIH HHS R01AI048849NIAID NIH HHS R01 AI065544NIAID NIH HHS R01AI065544NIAID NIH HHS R01 AI068129NIAID NIH HHS R21 AI077021NIAID NIH HHS R21AI077021NIAID NIH HHS R37 AI066897
6 · The paper itself

Abstract

It is well established that natural killer (NK) cells confer resistance to many viral diseases, but in only a few instances the molecular mechanisms whereby NK cells recognize virus-infected cells are known. Here we show that CD94, a molecule preferentially expressed by NK cells, is essential for the resistance of C57BL/6 mice to mousepox, a disease caused by the Orthopoxvirus ectromelia virus. Ectromelia virus-infected cells expressing the major histocompatibility complex (MHC) class Ib molecule Qa-1(b) are specifically recognized by the activating receptor formed by CD94 and NKG2E. Because CD94-NKG2 receptors and their ligands are highly conserved in rodents and humans, a similar mechanism may exist during human infections with the smallpox and monkeypox viruses, which are highly homologous to ectromelia virus.

Indexed as

AnimalsCell LineCell MovementEctromelia, InfectiousHumansKiller Cells, NaturalLymph NodesMiceNK Cell Lectin-Like Receptor Subfamily DNK Cell Lectin-Like Receptor Subfamily D

Identifiers

PMID21439856
PMCPMC3081423
OpenAlexW2049093000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.